TABLE 3.
QTL name | Chr. | Pos. (cM) | Left marker namea | Right marker name | LOD | PVE (%)b | Interval size (Mbp) |
CKT3.1 | Pv03 | 1.5 | Pv2.1_03_592656_G/A | Pv2.1_03_755530_G/C | 6.96 | 7.07 | 0.16 |
CKT4.1 | Pv04 | 47 | Pv2.1_04_41895594_A/T | Pv2.1_04_41987047_A/T | 7.03 | 7.60 | 0.09 |
CKT7.1 | Pv07 | 63.5 | Pv2.1_07_31833933_A/C | Pv2.1_07_32077935_T/C | 11.39 | 12.18 | 0.24 |
CKT8.1 | Pv08 | 77 | Pv2.1_08_60150805_T/C | Pv2.1_08_60180011_A/G | 9.01 | 9.77 | 0.02 |
WAC11.1 | Pv11 | 75 | Pv2.1_11_51537051_G/C | Pv2.1_11_51584833_C/G | 7.96 | 8.69 | 0.04 |
Information on founder haplotype effects is in Supplementary Table 4.
aPhysical position and polymorphism of the SNP according to reference version 2.1.
bPhenotypic variation explained.